Periodic Reporting for period 2 - ProSCAN (Prostate cancer diagnostics using a non-invasive test based on innovative glycan-based scanning)

Glycanostics aim to create a world where cancer will be diagnosed early and treated successfully. Glycanostics’ test would transform the cancer diagnostics process for EU deadliest cancers including Prostate Cancer (PCa). As early diagnosis is crucial for the success of the...